Breast tumors, both cancerous and non-cancerous, are one of the most serious health problems facing women today. Early detection is the most powerful tool in combating this problem. Coupled with early detection is the early treatment of tumors or "lumps" found in the breast.

Now women have a new option to treat fibroadenomas - Novilase, a minimally-invasive alternative to surgical lumpectomy.

Fibroadenomas are the most common type of solid breast tumor - affecting 10% of all women. Whether discovered through a self-breast examination or routine mammogram, the majority of women request surgical excision of the fibroadenoma, after consultation with their physician.

Novian Health recently received FDA clearance for Novilase, an image-guided laser ablation device for the treatment of fibroadenomas of the breast. Novian Health is planning a clinical trial to obtain FDA clearance of Novilase for malignant breast tumors.